European Radiology

, Volume 26, Issue 7, pp 2099–2106 | Cite as

IVIM DW-MRI of autoimmune pancreatitis: therapy monitoring and differentiation from pancreatic cancer

  • Miriam KlaußEmail author
  • Klaus Maier-Hein
  • Christine Tjaden
  • Thilo Hackert
  • Lars Grenacher
  • Bram Stieltjes



To evaluate IVIM DW-MRI for changes in IVIM-derived parameters during steroid treatment of autoimmune pancreatitis (AIP) and for the differentiation from pancreatic cancer (PC).


Fifteen AIP-patients, 11 healthy patients and 20 PC-patients were examined with DWI-MRI using eight b-values (50, 100, 150, 200, 300, 400, 600, 800). 12 AIP-patients underwent follow-up examinations during treatment. IVIM-parameters and ADC800-values were tested for significant differences and an ROC analysis was performed.


The perfusion fraction f was significantly lower in patients with AIP at the time of diagnosis (10.5 ± 4.3 %) than in patients without AIP (20.7 ± 4.3 %). In AIP follow-up, f increased significantly to 17.1 ± 7.0 % in the first and 21.0 ± 4.1 % in the second follow up. In PC, the f-values were lower (8.2 ± 4.0 %, n.s.) compared to initial AIP and were significantly lower compared to first and second follow-up examination. In the ROC-analysis AUC-values for f were 0.63, 0.88 and 0.98 for differentiation of PC from initial, first and second follow up AIP-examination.


The found differences in f between AIP, AIP during steroid treatment and pancreatic cancer suggest that IVIM-diffusion MRI could serve as imaging biomarker during treatment in AIP-patients and as a helpful tool for differentiation between PC and AIP.

Key Points

MRI is used for follow-up examinations during therapy in AIP-patients

IVIM-DWI-MRI offers parameters which reflect perfusion and true diffusion

IVIM-parameters are helpful for differentiation between AIP and pancreatic cancer

IVIM-parameters could serve as an imaging biomarker during steroid treatment


Pancreatitis Pancreatic carcinoma Diffusion Magnetic Resonance Imaging Diffusion-weighted MRI 



Autoimmune pancreatitis


Intravoxel incoherent motion


Diffusion-weighted imaging



The scientific guarantor of this publication is Miriam Klauss. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. This study has received funding by the German Research Foundation (DFG) Grant SFB/TRR 125 “Cognition guided surgery” (MK, KM-H, LG and BS). No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, diagnostic or prognostic study, performed at one institution.


  1. 1.
    Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A (2004) Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 39:1154–8CrossRefPubMedGoogle Scholar
  2. 2.
    Manfredi R, Graziani R, Cicero C et al (2008) Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 247:435–43CrossRefPubMedGoogle Scholar
  3. 3.
    Kloppel G, Luttges J, Lohr M, Zamboni G, Longnecker D (2003) Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 27:14–9CrossRefPubMedGoogle Scholar
  4. 4.
    Zamboni G, Luttges J, Capelli P et al (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–63CrossRefPubMedGoogle Scholar
  5. 5.
    Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T (2007) Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 42:28–31CrossRefPubMedGoogle Scholar
  6. 6.
    Frulloni L, Scattolini C, Falconi M et al (2009) Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 104:2288–94CrossRefPubMedGoogle Scholar
  7. 7.
    Kim HJ, Kim YK, Jeong WK, Lee WJ, Choi D (2015) Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas. Eur Radiol 25:1551–60CrossRefPubMedGoogle Scholar
  8. 8.
    Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505CrossRefPubMedGoogle Scholar
  9. 9.
    Klauss M, Lemke A, Grunberg K et al (2011) Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investig Radiol 46:57–63.10CrossRefGoogle Scholar
  10. 10.
    Kamisawa T, Takuma K, Anjiki H et al (2010) Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 105:1870–5CrossRefPubMedGoogle Scholar
  11. 11.
    Okazaki K, Kawa S, Kamisawa T et al (2006) Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 41:626–31CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Otsuki M, Chung JB, Okazaki K et al (2008) Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 43:403–8CrossRefPubMedGoogle Scholar
  13. 13.
    Manfredi R, Frulloni L, Mantovani W, Bonatti M, Graziani R, Pozzi MR (2011) Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology 260:428–36CrossRefPubMedGoogle Scholar
  14. 14.
    Sahani DV, Kalva SP, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–52CrossRefPubMedGoogle Scholar
  15. 15.
    Fritzsche KH, Neher PF, Reicht I et al (2012) MITK diffusion imaging. Methods Inf Med 51:441–8CrossRefPubMedGoogle Scholar
  16. 16.
    Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31:589–600CrossRefPubMedGoogle Scholar
  17. 17.
    Esposito I, Bergmann F, Penzel R et al (2004) Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis. Virchows Arch 444:119–26CrossRefPubMedGoogle Scholar
  18. 18.
    Rzepko R, Jaskiewicz K, Klimkowska M, Nalecz A, Izycka-Swieszewska E (2003) Microvascular density in chronic pancreatitis and pancreatic ductal adenocarcinoma. Folia Histochem Cytobiol / Pol Acad Sci, Pol Histochem Cytochem Soc 41:237–9Google Scholar
  19. 19.
    Hur BY, Lee JM, Lee JE et al (2012) Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging 36:188–97CrossRefPubMedGoogle Scholar
  20. 20.
    Klauss M, Gaida MM, Lemke A et al (2013) Fibrosis and pancreatic lesions: counterintuitive behavior of the diffusion imaging-derived structural diffusion coefficient d. Investig Radiol 48:129–33CrossRefGoogle Scholar
  21. 21.
    Kloppel G, Detlefsen S, Feyerabend B (2004) Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch 445:1–8CrossRefPubMedGoogle Scholar

Copyright information

© European Society of Radiology 2015

Authors and Affiliations

  • Miriam Klauß
    • 1
    Email author
  • Klaus Maier-Hein
    • 2
  • Christine Tjaden
    • 3
  • Thilo Hackert
    • 3
  • Lars Grenacher
    • 1
  • Bram Stieltjes
    • 4
  1. 1.Department of Diagnostic and Interventional RadiologyUniversity of HeidelbergHeidelbergGermany
  2. 2.Department of Medical and Biological InformaticsDKFZHeidelbergGermany
  3. 3.Department of SurgeryUniversity of HeidelbergHeidelbergGermany
  4. 4.Department of RadiologyUniversity Hospital BaselBaselSwitzerland

Personalised recommendations